KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Net Income (2019 - 2025)

Historic Net Income for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $1.1 million.

  • GoodRx Holdings' Net Income fell 7177.81% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.8 million, marking a year-over-year increase of 29578.27%. This contributed to the annual value of $16.4 million for FY2024, which is 28482.18% up from last year.
  • Per GoodRx Holdings' latest filing, its Net Income stood at $1.1 million for Q3 2025, which was down 7177.81% from $12.8 million recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Net Income registered a high of $58.8 million during Q2 2023, and its lowest value of -$41.7 million during Q3 2022.
  • Moreover, its 5-year median value for Net Income was $1.1 million (2025), whereas its average is -$1.3 million.
  • Within the past 5 years, the most significant YoY rise in GoodRx Holdings' Net Income was 425448.76% (2023), while the steepest drop was 121181.54% (2023).
  • GoodRx Holdings' Net Income (Quarter) stood at -$39.9 million in 2021, then skyrocketed by 95.06% to -$2.0 million in 2022, then plummeted by 1211.82% to -$25.9 million in 2023, then surged by 126.05% to $6.7 million in 2024, then tumbled by 83.4% to $1.1 million in 2025.
  • Its Net Income stands at $1.1 million for Q3 2025, versus $12.8 million for Q2 2025 and $11.1 million for Q1 2025.